We are looking for young people 2 to 17 years old to join a Crohn’s disease (CD) clinical research to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or gastrointestinal disease (including associated symptoms such as stomach pain, stomach pain, bloody stool, malnutrition and/or anemia), consider one of our medical research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the medical research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child is eligible.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local Crohn’s disease (CD) clinical research study is testing a potential new medication to see if it may reduce fatigue, inflammation of the bowel or intestine, abdominal pain, weight loss, and/or joint pain associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the Crohn’s disease (CD) clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child is eligible.

We are looking for young people 2–17 years of age to join a study to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or Crohn’s disease (including associated symptoms such as tiredness, iron deficiency, cramps, weight loss and/or joint pain), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your child or teen 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe UC flare-ups? Local research is testing a potential new medication to see if it may reduce abdominal pain, weight loss, constant need to poop, frequent fevers, and/or eye pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children and teenagers 2–17 years of age to join a CD research study to help us discover more about treating CD and UC. If you are looking for a potential new treatment option for CD and UC or ulcerative colitis (UC) (including associated symptoms such as tiredness, reduced appetite, bloody stool, frequent fevers and/or liver disease), consider one of our clinical research. All eligible participants will receive no-cost study-related care and study medication. Your children and teenagers 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to take part.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local trial is testing a potential new medication to see if it may reduce fatigue, stomach pain, bloody stool, malnutrition, and/or eye pain associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to take part.

We are looking for 2 to 17 years of age to join a Crohn’s disease study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or CD and UC (including associated symptoms such as abdominal cramps, blood in the stool, rectal pain, frequent fevers and/or eye pain), consider one of our Crohn’s disease (CD) clinical research. All eligible participants will receive no-cost study-related care and study medication. Your 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the Crohn’s disease (CD) clinical research if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease study is testing a potential new medication to see if it may reduce fever, perianal fistula, abdominal pain, weight loss, and/or canker sores associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for child to join a research to help us discover more about treating Crohn’s and ulcerative colitis. If you are looking for a potential new treatment option for Crohn’s and ulcerative colitis or moderate to severe UC (including associated symptoms such as chronic diarrhea, abdominal cramps, constant need to poop, weight loss and/or joint pain), consider one of our GI research studies. All eligible participants will receive no-cost study-related care and study medication. Your child may be eligible to take part.

Your child may be eligible to take part in the GI research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child may be able to to join.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce abdominal pain and cramps, reduced appetite, diarrhea, malnutrition, and/or liver disease associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child may be able to to join.